Malaria Consortium Guidance Document Published On Implementing Malaria consortium is a leading implementer of seasonal malaria chemoprevention (smc), a highly effective intervention to prevent malaria in those most vulnerable to the disease's effects. it involves administering monthly doses of antimalarial drugs to children aged 3 59 months during the peak malaria transmission season. To assess whether seasonal malaria chemoprevention can be an effective malaria prevention strategy in mozambique, malaria consortium initiated a two year hybrid effectiveness implementation study in nampula province in 2020, in partnership with the national malaria control programme (nmcp) and the centro de investigação em saúde da manhiça.
Malaria Consortium Coverage And Quality Of Seasonal Malaria Key takeaways: in 2023, 53 million children were protected by seasonal malaria chemoprevention (smc) in 18 countries. 1. chemoprevention has proven to be efficacious and cost effective, particularly in children, who are at the greatest risk of dying from malaria. given the large scale deployment, mmv supports optimal implementation of smc. The goal of this publication is to share these best practices to improve smc implementation, coverage, and monitoring and evaluation. examples of materials and tools as well as links to resources are included to support managers and health workers in their efforts to conduct successful smc activities and prevent malaria among vulnerable children. Smc was initially implemented in the northern states where malaria is most highly seasonal. smc implementation in nigeria started as a pilot project in six lgas (local government areas) of katsina state in 2013 and 2014. in 2014 the country adopted smc as a country wide policy, in those states meeting the eligibility criteria . Background seasonal malaria chemoprevention (smc) is a highly effective intervention for preventing malaria, particularly in areas with highly seasonal transmission. monitoring and evaluating (m&e) smc programmes are complex due to the scale, time sensitive delivery of the programme, and influence of external factors. this paper describes the process followed to develop a comprehensive m&e.
Comments are closed.